Amylyx Pharmaceuticals Inc (AMLX)
Statistics
Key valuation multiples, financial performance ratios, profitability metrics, and per share data consolidated into a single structured view. Each metric is benchmarked against both industry and sector averages — providing immediate context on whether the company is trading at a premium or discount relative to its direct peers and the broader market segment.
Valuation & Market Metrics
Market Capitalization
$3.88B
EV to revenue ratio (TTM)
6,446.63
EV to ebitda
-11.71
Financial Performance
Revenue (TTM)
-$0.00B
Gross profit (TTM)
-$0.09B
EBITDA
-$0.18B
Profitability
Operating margin (TTM)
<0.01%
Profit margin
<0.01%
Return on assets (TTM)
-19.10%
Return on equity (TTM)
-30.10%
Per Share Metrics
Revenue per share (TTM)
-$0.01
EPS
-$1.43
Diluted EPS (TTM)
-$1.43
Book value
$5.86
Dividend per share
n/a
Dividend yield
n/a
Valuation Multiples
P/E ratio
n/a
Trailing P/E
n/a
Forward P/E
2.77
PEG ratio
n/a
Price to sales ratio (TTM)
0.66
Price to book ratio (TTM)
5.03
Growth
Quarterly earnings growth (YoY)
-99.60%
Quarterly revenue growth (YoY)
<0.01%
Analyst Sentiment
Strong buy
0
Buy
11
Hold
1
Sell
0
Strong sell
0
Risk & Volatility
Beta
-0.08